Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
---|
01/03/2008 | WO2008001885A1 Abl KINASE INHIBITOR |
01/03/2008 | WO2008001502A1 Potentiator of radiation therapy |
01/03/2008 | WO2008001195A2 Novel processes for the preparation of dpp iv inhibitors |
01/03/2008 | WO2008001188A2 An improved process for the preparation of substantially pure aripiprazole |
01/03/2008 | WO2008000922A1 Sulphur-containing cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
01/03/2008 | WO2008000645A1 Tetrazole-substituted arylamides |
01/03/2008 | WO2008000643A1 Benzimidazole derivatives, method for the production thereof, their use as fxr agonists and pharmaceutical preparations containing the same |
01/03/2008 | WO2007130822A3 Mglur5 modulators iii |
01/03/2008 | WO2007125331A3 Amino-ethyl-amino-aryl (aeaa) compounds and their use |
01/03/2008 | WO2007117961A3 Renin inhibitors |
01/03/2008 | US20080004415 Non-linear optically active molecules, their synthesis, and use |
01/03/2008 | US20080004297 Compounds and therapeutical use thereof |
01/03/2008 | US20080004288 Indazole Sulphonamide Derivatives |
01/03/2008 | US20080004280 Heterocyclic topoisomerase poisons |
01/03/2008 | US20080004278 (1-phenyl-5-propyl-1H-pyrazol-4-yl)-(3-amino-N-cyclopropyl-4-methyl-benzamide)-amine; p38 mitogen-activated protein kinase inhibitor; reduced levels of TNF- alpha expression; antiinfammatory agent: rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease |
01/03/2008 | US20080004277 Triazole compounds that modulate HSP90 activity |
01/03/2008 | US20080004275 Antiviral 4-Aminocarbonylamino-Substituted Imidazole Compounds |
01/03/2008 | US20080004272 Compositions and methods for modulating gated ion channels |
01/03/2008 | US20080004269 Pyrazolylmethy Heteroaryl Derivatives |
01/03/2008 | US20080004268 e.g. 4-tert-Butyl-N-[3-phenyl-2-(pyrrolidine-1-carbonyl)-1H-indol-5-yl]-benzenesulfonamide; contraceptive; for male fertility control; act on testicular stem cells and mature sperm |
01/03/2008 | US20080004259 Anticancer agents; initiating mitosis which causes tumor cell death |
01/03/2008 | US20080004257 Kinase inhibitors |
01/03/2008 | US20080004242 Process for preparation of HIV protease inhibitors |
01/03/2008 | US20080003283 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; preparing, for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile |
01/03/2008 | US20080003214 Medicaments Comprising Carbonyl Compounds, And The Use Thereof |
01/03/2008 | US20080001534 Methods of making tris(N-aryl benzimidazoles)benzenes and their use in electronic devices |
01/03/2008 | CA2658362A1 Metalloprotease inhibitors |
01/03/2008 | CA2656564A1 Biaryl compositions and methods for modulating a kinase cascade |
01/03/2008 | CA2656165A1 Bicyclic compositions and methods for modulating a kinase cascade |
01/03/2008 | CA2655444A1 New compounds 385 |
01/03/2008 | CA2655441A1 New compounds 384 |
01/03/2008 | CA2654915A1 Tetrazole-substituted arylamides |
01/03/2008 | CA2652811A1 Potentiator of radiation therapy |
01/03/2008 | CA2647601A1 Pyrrole derivatives and their methods of use |
01/03/2008 | CA2631506A1 Sulphur-containing cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
01/02/2008 | EP1873152A1 Novel purification process of moxonidine |
01/02/2008 | EP1873151A1 Improved process for producing moxonidine |
01/02/2008 | EP1873147A1 Phthalazinone derivative and pharmaceutical comprising the same |
01/02/2008 | EP1871768A1 Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors |
01/02/2008 | EP1871767A1 Crystal of aminopyrrolidine derivative and prodcution method thereof |
01/02/2008 | EP1871766A1 Antifungal triazole derivatives |
01/02/2008 | EP1871765A2 3-(indazol-5-yl)-(1,2,4)triazine derivatives and related compounds as protein kinase inhibitors for the treatment of cancer |
01/02/2008 | EP1871764A1 A synthesis of 4-bromomethyl-2'-formylbiphenyl and 4-bromomethyl-2'- hydroxymethylbiphenyl and its use in preparation of angiotensin ii antagonists |
01/02/2008 | EP1871762A2 Subtituted heteroaryl cb1 antagonists |
01/02/2008 | EP1871749A1 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands |
01/02/2008 | EP1871746A1 Substituted n-[ypyrimidin-2-ylmethyl]carboxamides and their use as herbicides and plant growth regulators |
01/02/2008 | EP1871374A2 2,3 substituted pyrazine sulfonamides as inhibitors of crth2 |
01/02/2008 | EP1414797B1 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
01/02/2008 | EP1414441B1 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
01/02/2008 | EP1335915B1 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
01/02/2008 | EP1282605B1 Thioimidazolidine derivatives as light stabilisers for polymers |
01/02/2008 | CN101098858A 吲唑磺酰胺衍生物 Indazole sulfonamide derivative |
01/02/2008 | CN101096367A Triazine radical amido diphenyl ethylene fluorescent bleaches |
01/02/2008 | CN100358890C 喹唑啉衍生物类激酶抑制剂 Quinazoline derivatives kinase inhibitors |
01/02/2008 | CN100358888C Novel guanidine mimics as factor Xa inhibitors |
01/02/2008 | CN100358869C Carbamate caspase inhibitors and uses thereof |
01/01/2008 | US7314938 Immune and/or inflammatory disorders; autoimmune disorders; disorders mediated by the CD11/CD18 family of cellular adhesion molecules (e.g., LFA-1); antagonize CD11/CD18 receptors associated with leukocytes. |
01/01/2008 | US7314933 Vanilloid receptor ligands and their use in treatments |
01/01/2008 | US7314932 Methods for minimizing thioamide impurities |
01/01/2008 | US7314885 (4-(4-(2,3-difluorophenyl)-4H-1,2,4-triazol-3-yl)-1H-pyrrol-2-yl)(2H-pyrrol-1(5H)-yl)methanone; anticarcinogenic, antiproliferative and antimetastasis agent; inhibitors of c-Met protein kinase |
01/01/2008 | US7314884 non-insulin dependent diabetes mellitus, and impaired glucose tolerance; dipeptidyl peptidase IV (DPP-IV) inhibitors eg (2S)-1-{[(1S)-2-(5-cyano-2-methyl-indol-1-yl)-1-methyl-ethylamino]-acetyl}-pyrrolidine-2-carbonitrile |
01/01/2008 | US7314876 Administering to mammals nitrogen compounds, as mitogen activated kinase inhibitors, for prophylaxis asthma, respiratory system disorders, graft versus host disease, atherosclerosis and arthritis |
12/27/2007 | WO2007150010A2 Cyclopropyl amine derivatives as histamin h3 receptor modulators |
12/27/2007 | WO2007149478A2 Pyrazine derivatives with extended conjugation and uses thereof |
12/27/2007 | WO2007149448A2 Pyrazinones as cellular proliferation inhibitors |
12/27/2007 | WO2007149033A1 Substituted isoindoles as bace inhibitors and their use |
12/27/2007 | WO2007148774A1 Cyclic amine compound |
12/27/2007 | WO2007148185A2 Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors |
12/27/2007 | WO2007148070A1 Chemical compounds |
12/27/2007 | WO2007147874A1 Pyridine and pyrazine derivatives as mnk kinase inhibitors |
12/27/2007 | WO2007147746A1 2-pyrazinecarboxamide derivatives |
12/27/2007 | WO2007147659A1 Adenosine a3 receptor agonists |
12/27/2007 | WO2007124254A3 Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
12/27/2007 | WO2007120980A3 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases |
12/27/2007 | WO2007117565A9 Standardization of processes for culturing primary cells |
12/27/2007 | WO2007115077A3 Bicyclic benzimidazole compounds and their use as metabotropic glutamate receptor potentiators |
12/27/2007 | WO2007099402A3 New 3’-, 7-substituted indirubins and their applications |
12/27/2007 | WO2007092558A3 Sulfonamide derivatives to treat infection with hepatitis c virus |
12/27/2007 | WO2007047306A8 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors |
12/27/2007 | US20070299126 Substituted pyrrole-indoles |
12/27/2007 | US20070299125 Substituted indoles |
12/27/2007 | US20070299109 Dimeric Compounds Of Piperidine, Piperazine Or Morpholine Or Their 7-Membered Analogs Suitable For The Treatment Of Neurodegenerative Disorders |
12/27/2007 | US20070299092 Quinone Substituted Quinazoline and Quinoline Kinase Inhibitors |
12/27/2007 | US20070299085 N1-((Pyrazol-1-Ymethyl)-2-Methylphenyl)-Phatalamide Derivatives And Related Compounds Insecticides |
12/27/2007 | US20070299076 Substituted 3-Amino-Pyrrolidino-4-Lactams |
12/27/2007 | US20070299073 Imidazolyl derivatives |
12/27/2007 | US20070299070 Such as 5-(benzyloxy)-N-[4-(morpholinomethyl)phenyl]-1H-indole-2-carboxamide and 5-(benzyloxy)-N-[4-(morpholinomethyl)phenyl]-1H-benzimidazole-2-carboxamide; melanin-concentrating hormone receptor antagonist, useful for treating obesity |
12/27/2007 | US20070299069 Methods for treating hepatitis C |
12/27/2007 | US20070299068 viricides comprising (3-cyano-indol-2-yl)phenyl derivatives, used for for treating viral diseases and infections or for affecting viral internal ribosome entry site (IRES) activity |
12/27/2007 | US20070299063 N3 alkylated benzimidazole derivatives as mek inhibitors |
12/27/2007 | US20070299060 (1R,2R,3S,4S)-5-fluoro-N4-[3- methylaminocarbonylbicyclo[2.2.1]hept-5- en-2-yl)-N2-[1-methylsulfonyl-2,3- dihydroindol-5-yl]-2,4-pyrimidinediamine, used to inhibit cellular proliferation and to treat proliferate diseases such as tumorigenic cancers |
12/27/2007 | US20070299059 Compostions and methods relating to novel compounds and targets thereof |
12/27/2007 | US20070299056 Benzazepine derivatives for the treatment of neurological disorders |
12/27/2007 | US20070298507 Fluorescent Probe |
12/27/2007 | US20070298108 Pharmaceutical Formulation |
12/27/2007 | CA2656625A1 Substituted isoindoles as bace inhibitors and their use |
12/27/2007 | CA2655857A1 Pyrazine derivatives with extended conjugation and uses thereof |
12/27/2007 | CA2655604A1 Cyclopropyl amine derivatives |
12/27/2007 | CA2654781A1 2-pyrazinecarboxamide derivatives |
12/27/2007 | CA2654358A1 Pyridine and pyrazine derivatives as mnk kinase inhibitors |